Ochratoxin A
From ToxBankWiki
Executive Summary Information
Compound | Ochratoxin A (OTA) |
Toxicities | Renal carcinogenicity and nephrotoxicity. |
Mechanisms | Non-genotoxic carcinogen. It is likely that it interferes with cytoskeletal structures causing aberrant mitosis. |
Comments | This compound was chosen for the study of epigenetic effects in renal cells. SAFETY CAUTION: This compound is one of the most potent renal carcinogens known in rats and should be handled with extreme care. |
Feedback Contact | Gold Compound Working Group (GCWG) |
Ochratoxin A | |
---|---|
| |
Identifiers | |
Leadscope Id | LS-1157 |
CAS | 303-47-9 |
ChemSpider | 390954 |
ChEBI | 7719 |
Pathway DBs | |
KEGG | C09955 |
Assay DBs | |
PubChem CID | 442530 |
ChEMBL | 589366 |
Omics DBs | |
Properties | |
ToxCast Accepted | no |
ToxBank Accepted | yes |
Approved on | 2012-10-23 |
|
|
|
|
Calculated/Predicted Properties
|
|